Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These findings may explain the causes of the debilitating symptoms and…
Emily Ruether, MD, has built a career around the treatment of movement disorders. In this video, she discusses her approach to helping patients with certain conditions resume the…
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
There is a new study that suggests there may be an easy way to diagnose Parkinson’s Disease from other similar diseases early on. This method relies on measuring…
A new drug called Austedo, has been approved by the FDA for the treatment of involuntary movements associated with chorea. Austedo is a small molecule drug designed to…
